Search hospitals > Texas > Dallas
University of Texas Southwestern Medical Center
Claim this profileDallas, Texas 75390
Global Leader in Cancer
Global Leader in High Blood Pressure
Conducts research for Diabetes
Conducts research for Depression
Conducts research for Fibrosis
2260 reported clinical trials
220 medical researchers
Summary
University of Texas Southwestern Medical Center is a medical facility located in Dallas, Texas. This center is recognized for care of Cancer, High Blood Pressure, Diabetes, Depression, Fibrosis and other specialties. University of Texas Southwestern Medical Center is involved with conducting 2,260 clinical trials across 1,692 conditions. There are 220 research doctors associated with this hospital, such as David Miller, MD, Patrick Leavey, MD, Syed M. Kazmi, and Nitin Jain, MD.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2High Blood Pressure
Global LeaderStage I
6MWD
CTD-ILD
Top PIs
David Miller, MDParkland Memorial Hospital2 years of reported clinical research
Expert in Cancer
Studies Ovarian Cancer
20 reported clinical trials
39 drugs studied
Patrick Leavey, MDUT Southwestern/Simmons Cancer Center-Dallas3 years of reported clinical research
Studies Tumors
Studies Sarcoma
16 reported clinical trials
34 drugs studied
Syed M. KazmiUT Southwestern/Simmons Cancer Center-Dallas1 year of reported clinical research
Expert in Colorectal Cancer
Studies Colon Cancer
17 reported clinical trials
33 drugs studied
Nitin Jain, MDM D Anderson Cancer Center7 years of reported clinical research
Expert in Leukemia
Studies Lymphoid Leukemia
15 reported clinical trials
23 drugs studied
Clinical Trials running at University of Texas Southwestern Medical Center
Kidney Stones
Multiple Myeloma
Plasma Cell Neoplasms
Renal Cell Carcinoma
Non-Small Cell Lung Cancer
Bladder Cancer
Cystic Fibrosis
Cancer
B-Cell Lymphoma
Parkinson's Disease
Pioglitazone + Weight Loss
for Kidney Stones
This trial tests the effects of Pioglitazone, weight loss, or both in overweight and obese patients with uric acid kidney stones. Pioglitazone helps the body use insulin better and reduces urine acid, while weight loss improves health and reduces the risk of stones.
Recruiting3 awards Phase 44 criteria
Tenapanor
for Kidney Stones
This pilot study is proposing a novel approach to directly target intestinal oxalate absorption with the drug Tenapanor, which was recently FDA-approved for treating hyperphosphatemia in patients with chronic kidney disease. Tenapanor works by blocking paracellular phosphate absorption by the intestine, but the underlying mechanisms have not been clearly defined. Since phosphate and oxalate ions are absorbed through the same paracellular pathway, and are of similar size and charge, Tenapanor is hypothesized to also reduce dietary oxalate absorption and consequently lower urinary oxalate excretion.
Recruiting2 awards Phase 41 criteria
Hydroxycitrate
for Kidney Stones
This trial tests whether hydroxycitrate can reduce the recurrence of kidney stones in patients who frequently get them. It compares hydroxycitrate to potassium citrate. The treatment works by preventing the formation of crystals that cause kidney stones. Hydroxycitrate is a derivative of citric acid and has shown the ability to inhibit the formation of calcium oxalate crystals in vitro.
Recruiting2 awards Phase 41 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Texas Southwestern Medical Center?
University of Texas Southwestern Medical Center is a medical facility located in Dallas, Texas. This center is recognized for care of Cancer, High Blood Pressure, Diabetes, Depression, Fibrosis and other specialties. University of Texas Southwestern Medical Center is involved with conducting 2,260 clinical trials across 1,692 conditions. There are 220 research doctors associated with this hospital, such as David Miller, MD, Patrick Leavey, MD, Syed M. Kazmi, and Nitin Jain, MD.
Where is University of Texas Southwestern Medical Center located?
The University of Texas Southwestern Medical Center is situated at 5323 Harry Hines Blvd, Dallas, Texas, United States. For access, use I-35E N, exit at Medical District Drive, and proceed west towards Harry Hines Blvd; the center is located on the left side.
Who should I call to ask about financial aid or insurance network?
**University of Texas Southwestern Medical Center - Financial Assistance and Contact Information**
- **Financial Assistance Department:** For assistance, call 469-291-2000 or toll-free at 866-648-2455, Monday through Friday, 8:00 a.m. to 5:00 p.m. Mail completed applications and required documentation to FinancialAssistance@UT Southwestern Medical Center (Mail Code 9233), P.O. Box 36423, Dallas, Texas 75235-9662.
- **Billing and Insurance Questions:** Contact the Account Resolutions Department at 469-291-2000 or toll-free at 866-648-2455, online via MyChart, or by mail at P.O. Box 848009, Dallas, TX 75284-8009.
- **General Information:** Call 214-648-3111 or write to UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390.
What insurance does University of Texas Southwestern Medical Center accept?
The University of Texas Southwestern Medical Center accepts a wide range of major medical insurance plans. These include, but are not limited to, Aetna, Blue Cross Blue Shield Texas, Humana, UnitedHealthcare, and Wellcare. For a detailed list of specific insurance plans accepted, particularly by UT Physicians, patients are advised to verify their coverage directly with the clinical practice or hospital.
What awards or recognition has University of Texas Southwestern Medical Center received?
The University of Texas Southwestern Medical Center, located in Dallas, Texas, is ranked as the #1 hospital in Texas (tie) and among the top 20 in the nation for 2023-24 by U.S. News & World Report, with 11 of its specialties recognized in the top 50 nationally. It has earned accolades for diversity and inclusion, being named a Top LGBTQ+ Friendly Company and a Top Healthcare Company by notable publications. The center's research programs, funded by approximately $554.4 million annually, have made significant contributions, including the development of statin drugs and the discovery of gene variants affecting LDL cholesterol levels in the Dallas Heart Study.